Generic Products

Based on our presence in the many countries and networks Hexaphoenix is representing a number of nationally and internationally renowned companies who develop and contract manufacture generic products from EUGMP plants including European and Indian manufacturing facilities. We thus offer a range of differentiated finished drug products as projects for In-Out Licensing or contract manufacturing services from our partner research and developments.

We have expertise covering a variety of therapeutic areas such as CNS, CVS, Oncology, Urology, Gynecology, Gastro-Entomology, Cardiology in different Pharmaceutical formulations such as oral Tablets, Capsules, Syrup, Injectable and external topical formulations. In addition to being the expert in Herbal and Natural Cosmeceutical solutions.

Quality Policy

Hexaphoenix is committed towards Manufacturing and Marketing of pharmaceuticals products, following an integrated QUALTY MANAGEMENT SYSTEM (QMS) meet customer and regulatory requirements to ensure Quality, Safety and Efficacy of our products.

For further more detailed information on product opportunities and services, please contact us:

Strength: 100mg /200mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 75mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg /500mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/20mg/30mg/40mg/60mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30mg/60mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 40/160mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 500mg/750mg/1000mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: Prochlorperazine |  Tablet |  5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 7.5mg/5ml, 30mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5/10/20/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 375mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 800mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg / 7.5mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 50/100mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 12.5/25/50/100mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 0.5mg / 0.75mg / 1.0mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg

Dosage: ODT (Lingual) Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 8mg /16mg / 24mg /48mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 0.5mg / ml

Dosage: Oral Solution

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 500 mg / 1000mg

Dosage: Granules in Sachet

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 1mg/5mg/10mg

Dosage: Film Coated Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 62.5 mcg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 5 IU and 10 IU

Dosage: Injection

Approved Authority: WHO Prequalified and From EUGMP Approved Plant

Dossiers Available: Ready CTD

Bioequivalence (BE/BA) study: Not Required for Injection

Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.